Max Freebairn
Associate

Max is a UK and European patent attorney in the Chemistry and Pharmaceuticals team. He has experience in drafting, prosecution and strategic portfolio management, with a particular focus on small molecules and PROTACs. Max also regularly handles opposition and appeal work before the European Patent Office.

Max joined Elkington and Fife in 2022, after completing a BSc and MRes in Chemistry at the University of Durham. His MRes project investigated N-acyliminium cyclisations in the context of drug design, as a route to producing complex, biologically active structures.